Interoperability platform: Review of existing Identity Resolution and Mapping Services

The Interoperability Platform started to review existing Identity Resolution and Mapping Services and define the criteria against which they can be assessed for use as ELIXIR services. The criteria will be informed by the EXCELERATE and CORBEL Use Cases as well as those in the wider life sciences community and will help guide the provisioning of Identifier Services. In collaboration with the EXCELERATE Use Cases, we will also establish the identifier authorities and drive best practice for the identifiers use by applying the 10 identifier rules defined by BioMedBridges.

More information ยป

Tue 3 November 2015